End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.67 MYR | +0.75% | +1.52% | -2.90% |
Apr. 17 | Rhone Ma to Pay Final Dividend | MT |
Apr. 16 | Rhone Ma Holdings Berhad Announces Final Single Tier Dividend in Respect of the Financial Year Ended 31 December 2023, Payable on July 15, 2024 | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.90% | 31.09M | - | ||
+25.83% | 661B | C+ | ||
+27.00% | 566B | B | ||
-6.76% | 352B | C+ | ||
+20.34% | 332B | B- | ||
+3.00% | 283B | C+ | ||
+13.09% | 231B | B+ | ||
+5.46% | 200B | B- | ||
-9.61% | 195B | A+ | ||
-6.26% | 145B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- RHONEMA Stock
- Ratings Rhone Ma Holdings